Literature DB >> 14634274

Epidermal growth factor receptor: its role in Drosophila eye differentiation and cell survival.

P Kurada1, K White.   

Abstract

The Drosophila epidermal growth factor receptor (EGFR), functioning through the Ras/Raf/MAPK pathway, promotes cell proliferation and differentiation. Recent work has demonstrated that EGFR functions via the same Ras/Raf/MAPK pathway to promote cell survival. This review summarizes the role of EGFR in differentiation and survival during Drosophila eye development.

Entities:  

Year:  1999        PMID： 14634274     DOI： 10.1023/a:1009648724937

Source DB:  PubMed          Journal:  Apoptosis        ISSN： 1360-8185            Impact factor:   4.677


  4 in total

Review 1.  Intracellular trafficking in Drosophila visual system development: a basis for pattern formation through simple mechanisms.

Authors:  Chih-Chiang Chan; Daniel Epstein; P Robin Hiesinger
Journal:  Dev Neurobiol       Date:  2011-12       Impact factor: 3.964

2.  Impairment of ubiquitylation by mutation in Drosophila E1 promotes both cell-autonomous and non-cell-autonomous Ras-ERK activation in vivo.

Authors:  Hua Yan; Mei-Ling Chin; Elizabeth A Horvath; Elizabeth A Kane; Cathie M Pfleger
Journal:  J Cell Sci       Date:  2009-04-14       Impact factor: 5.285

3.  Drosophila activated Cdc42 kinase has an anti-apoptotic function.

Authors:  Jessica A Schoenherr; J Michelle Drennan; Juan S Martinez; Madhusudana Rao Chikka; Mark C Hall; Henry C Chang; James C Clemens
Journal:  PLoS Genet       Date:  2012-05-17       Impact factor: 5.917

4.  A KCNC3 mutation causes a neurodevelopmental, non-progressive SCA13 subtype associated with dominant negative effects and aberrant EGFR trafficking.

Authors:  Swati Khare; Jerelyn A Nick; Yalan Zhang; Kira Galeano; Brittany Butler; Habibeh Khoshbouei; Sruti Rayaprolu; Tyisha Hathorn; Laura P W Ranum; Lisa Smithson; Todd E Golde; Martin Paucar; Richard Morse; Michael Raff; Julie Simon; Magnus Nordenskjöld; Karin Wirdefeldt; Diego E Rincon-Limas; Jada Lewis; Leonard K Kaczmarek; Pedro Fernandez-Funez; Harry S Nick; Michael F Waters
Journal:  PLoS One       Date:  2017-05-03       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.